Login
$IRWD
$4.76 -$0.09 (1.85%) After hours

$IRWD SEC Filings

Filed On Filing
16 Nov 2026 SCHEDULE 13G/A
13 Nov 2026 144
10 Nov 2026 SCHEDULE 13G
05 Nov 2026 FORM S-8
05 Nov 2026 10-Q
05 Nov 2026 8-K: Results of Operations and Financial Condition

Ironwood Pharmaceuticals Raises Full-Year 2026 Financial Guidance Driven by Continued LINZESS U.S. Net Sales Growth and Strong Third Quarter Financial Performance

28 Oct 2026 SCHEDULE 13G/A
16 Oct 2026 8-K: Departure/Election of Directors or Officers; Compensation

– Tom McCourt to Retire from CEO Post After 17 Years at Ironwood and Four Decades of Distinguished Industry Leadership Bringing Transformational Medicines to Patients –

23 Sep 2026 144
17 Sep 2026 Form 4: Denner Alexander J, Director

Received 3,694 shares as a grant or award

14 Aug 2026 SCHEDULE 13G/A
07 Aug 2026 SCHEDULE 13G
06 Aug 2026 10-Q
06 Aug 2026 8-K: Results of Operations and Financial Condition

– Raises full-year 2026 LINZESS® (linaclotide) U.S. net sales guidance to $1.15 - $1.20 billion, representing greater than 30% increase year-over-year; Raises total revenue guidance to $460 - $485 million and adjusted EBITDA guidance to ...

28 Jul 2026 SCHEDULE 13G/A
22 Jul 2026 Form 4: Silber Jeffrey, SVP, CMO, Head-Res&Drug

Received 137,036 shares as a grant or award

22 Jul 2026 Form 3: Silber Jeffrey, SVP, CMO, Head-Res&Drug

No securities owned

09 Jul 2026 Form 4: Silver Ronald, PFO & PAO

Sold 127,890 shares ($578K)

07 Jul 2026 144
18 Jun 2026 8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders

This Amendment No. 1 (this “Amendment”) is made to the Amended and Restated 2019 Equity Incentive Plan (the “Plan”) of Ironwood Pharmaceuticals, Inc. (the “Company”).

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support